Shariq, M.; Mahmood, T.; Kushwaha, P.; Parveen, S.; Shamim, A.; Ahsan, F.; Wani, T.A.; Zargar, S.; Wasim, R.; Wahajuddin, M.
Fabrication of Nanoformulation Containing Carvedilol and Silk Protein Sericin against Doxorubicin Induced Cardiac Damage in Rats. Pharmaceuticals 2023, 16, 561.
https://doi.org/10.3390/ph16040561
AMA Style
Shariq M, Mahmood T, Kushwaha P, Parveen S, Shamim A, Ahsan F, Wani TA, Zargar S, Wasim R, Wahajuddin M.
Fabrication of Nanoformulation Containing Carvedilol and Silk Protein Sericin against Doxorubicin Induced Cardiac Damage in Rats. Pharmaceuticals. 2023; 16(4):561.
https://doi.org/10.3390/ph16040561
Chicago/Turabian Style
Shariq, Mohammad, Tarique Mahmood, Poonam Kushwaha, Saba Parveen, Arshiya Shamim, Farogh Ahsan, Tanveer A. Wani, Seema Zargar, Rufaida Wasim, and Muhammad Wahajuddin.
2023. "Fabrication of Nanoformulation Containing Carvedilol and Silk Protein Sericin against Doxorubicin Induced Cardiac Damage in Rats" Pharmaceuticals 16, no. 4: 561.
https://doi.org/10.3390/ph16040561
APA Style
Shariq, M., Mahmood, T., Kushwaha, P., Parveen, S., Shamim, A., Ahsan, F., Wani, T. A., Zargar, S., Wasim, R., & Wahajuddin, M.
(2023). Fabrication of Nanoformulation Containing Carvedilol and Silk Protein Sericin against Doxorubicin Induced Cardiac Damage in Rats. Pharmaceuticals, 16(4), 561.
https://doi.org/10.3390/ph16040561